Viewing Study NCT00031993


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-01-03 @ 1:24 PM
Study NCT ID: NCT00031993
Status: COMPLETED
Last Update Posted: 2013-01-17
First Post: 2002-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module